Article · 2 Apr 2024
Research articlePublished 13 May 2018
In vitro activity of aminoglycosides, lactam- lactamases inhibitor combinations and tetracyclines against multi-drug resistant Acinetobacter baumannii, isolated from a tertiary care hospital
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Acinetobacter baumannii has emerged as a significant nosocomial pathogen, particularly in intensive care units. Isolates of A. baumannii resistant to major groups of antibiotics have been identified. These multi-drug resistant (MDR) organisms are limiting the treatment options. The study was performed to determine the in vitro activity of aminoglycosides, lactam- lactamase inhibitor combinations and tetracyclines against MDR A. baumannii, isolated from a tertiary care hospital. The study was carried out from January, 2009 - August, 2009, at the Department of Microbiology, Army Medical College/National University of Sciences and Technology, Rawalpindi, Pakistan looking after an 1100 bedded tertiary care hospital. Routine clinical specimens were received from various wards. A. baumannii was identified by using standard microbiological procedures. Antimicrobial susceptibility test (gentamicin, amikacin, tobramycin, ampicillin-sulbactam, piperacillin-tazobactam, cefoperazonesulbactam, tetracycline, doxycycline, minocycline, tigecycline,) was performed according to CLSI guidelines using Kirby- Bauer disc diffusion technique. Resistance to carbapenems, fluoroquinolones and the beta-lactams were observed in significant proportion of fifty isolates. Among the aminoglycosides, the isolates were more susceptible to tobramycin than gentamicin and amikacin. Cefoperazone-sulbactam was superior to piperacillin-tazobactam and ampicillin -sulbactam in activity against MDR A. baumannii. Both tigecycline and minocycline were the active agents against most isolates. Multidrug resistant Acinetobacter infections are posing an increasing threat to our population. Minocycline, tobramycin and cefoperazone-sulbactam provide an effective option against infections caused by resistant A. baumannii.
Keywords
Subjects
MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Advanced Journal of Microbiology Research.
Article · 29 Mar 2024
Cultivating the future: Harnessing the microbiome for agriculture
Article · 29 Mar 2024
The hidden ecological roles and biotechnological potential of dark matter microbes
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAdvanced Journal of Microbiology Research
- SubjectMicrobiology
- BylineArticles whose byline prints “Afreenish Hassan”
- BylineArticles whose byline prints “Javaid Usman”
- BylineArticles whose byline prints “Fatima Kaleem”
- BylineArticles whose byline prints “Aslam Khan”
- BylineArticles whose byline prints “Zakir Hussain”